The authors propose that ceramide's ability to alter membrane structure and fusion compromises endocytic trafficking, but the specific molecular mechanisms are not explained. This mechanistic gap limits understanding of how sphingolipid metabolism directly impacts neuronal function in neurodegeneration. Gap type: unexplained_observation Source paper: Aberrant sphingomyelin/ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related neurodegeneration. (2003, Advanced drug delivery reviews, PMID:14597144)
Landscape Summary: How does ceramide accumulation mechanistically compromise endocytic trafficking in neurons? is a 0.83 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How does ceramide accumulation mechanistically compromise endocytic trafficking in neurons? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: